Shots: NICE has issued a positive Final Appraisal Document which recommends Sunosi (75/150mg, qd) as an option treatment for adults with EDS caused by narcolepsy with/out cataplexy. The therapy will […]readmore
Tags : solriamfetol
Shots: The MAA is based on four studies included in TONES program assessing Sunosi (75mg/150mg or 37.5mg, 75mg and 150 mg) vs PBO in 900+ adults with EDS associated with […]readmore
Shots: The approval is based on P-III TONES study assessing Sunosi (solriamfetol) vs PBO in 900 patients with excessive daytime sleepiness associated with narcolepsy or Obstructive Sleep Apnea (OSA) The […]readmore